The Evolution of Diagnostic Boundaries of Alzheimer’s Disease and Novel Therapeutic Options
Over the past three decades, the definition and diagnostic boundaries of Alzheimers disease (AD) have been repeatedly revised due to significant progress in understanding of the pathogenesis of neurodegeneration associated with Alzheimers disease and in the development of high-tech diagnostic method...
Main Author: | Svetlana Gavrilova |
---|---|
Format: | Article |
Language: | English |
Published: |
Eco-Vector
2022-01-01
|
Series: | Consortium Psychiatricum |
Subjects: | |
Online Access: | https://consortium-psy.com/jour/article/viewFile/152/pdf |
Similar Items
-
Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics in Alzheimer’s Disease
by: Mohammad Arastoo, et al.
Published: (2020-11-01) -
Construction and evaluation of Alzheimer’s disease diagnostic prediction model based on genes involved in mitophagy
by: Yongyan Pei, et al.
Published: (2023-03-01) -
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
by: Henrik Zetterberg, et al.
Published: (2021-02-01) -
Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer’s disease
by: Bin Zhang, et al.
Published: (2023-03-01) -
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
by: Miyo K. Chatanaka, et al.
Published: (2024-02-01)